TERT and thyroid gland papillary carcinoma: Our results further confirm the prognostic value of TERT mutations in the overall population of papillary thyroid cancer patients, demonstrating a nearly 1.9-fold increase in the risk of mortality (HR = 1.90, 95% CI: 1.17–4.77).